Web capturing of Sessions has been made possible through the support of Amgen and Lilly Oncology:

24 September 2009 

Teaching Lecture: Portrait of invasive lobular carcinoma of the breast

B.C. Pestalozzi (Switzerland)

Portrait of invasive lobular carcinoma of the breast  

Educational Symposium: Management and interpretation of novel toxicities of molecular targeted therapies

S. Tejpar (Belgium)

Skin toxicities of targeted therapies  

J. Carles (Spain)

Renal toxicities  

L.L. Siu (Canada)

Cardiovascular toxicity of molecularly targeted agents  

Teaching Lecture: Personalised radiotherapy - what is evidence-based?

C. Belka (Germany)

Personalised radiotherapy - what is evidence-based?  

Teaching Lecture: Evidence-based medicine: development and implementation of treatment guidelines in oncology

N. Pavlidis (Greece)

Evidence-based medicine: development and implementation of guidelines in oncology  

Teaching Lecture: How to use functional imaging information for radiotherapy planning

V. Gregoire (Belgium)

Functional image-guided intensity modulated radiation therapy: integration of the tumour microenvironment in treatment planning  

Educational Symposium: Chemoprevention of major cancers: the latest news

A. Decensi (Italy)

The rationale and potential of cancer chemoprevention with special emphasis on breast cancer  

F.H. Schröder (The Netherlands)

Prostate cancer - chemoprevention  

N. Arber (Israel)

Colorectal cancer chemoprevention: ready for practice?  

Teaching Lecture: Advances in early rectal cancer treatment

S.P. Bach (United Kingdom)

Advances in early rectal cancer treatment  

Teaching Lecture: Cervical cancer and vaccination- an overview

E. Joura (Austria)

Cervical cancer and vaccination- an overview  

Teaching Lecture: Desmoid-type fibromatosis: what works best ?

A. Gronchi (Italy)

Desmoid-type fibromatosis: what works best ?  

Teaching Lecture: Psycho-science: where do we go from here?

L.G. Walker (United Kingdom)

Psycho-science: where do we go from here?  

23 September 2009 

Teaching Lecture: Subclassification of ovarian cancer based on pathology and genetics

J. Prat (Spain)

Subclassification of ovarian cancer based on pathology and genetics  

Teaching Lecture: Screening for colorectal cancer, where are we now?

N. Arber (Israel)

Screening for colorectal cancer, where are we now?  

Teaching Lecture: IMRT and molecular biological approaches in radiotherapy for prostate cancer

R. Bristow (Canada)

IMRT and molecular biological approaches in radiotherapy for prostate cancer  

Educational Symposium: Oncogenes revisited

W. Gullick (United Kingdom)

The epidermal growth factor system of ligands and receptors in cancer  

D. Tuveson (United Kingdom)

RAS in cellular transformation and senescence  

S. Faivre (France)

The role of mTOR in cancer  

V. Rotter (Israel)

P53: balancing tumour suppression and implications for the clinic  

Teaching Lecture: The challenge of interacting with patients in oncology

N.I. Cherny (Israel)

The challenge of interacting with patients in oncology  

Teaching Lecture: Pharmacokinetics and pharmacodynamic biomarkers in early oncology drug development

C.H. Takimoto (USA)

Pharmacokinetics and pharmacodynamic biomarkers in early oncology drug development  

Teaching Lecture: Cardiac disease and second lung cancer after radiotherapy for breast cancer

C. Correa (USA)

Cardiac disease and second lung cancer after radiotherapy for breast cancer  

Educational Symposium: Advances in neuroendocrine tumours

K. Oberg (Sweden)

Neuroendocrine GEP -Tumors

G. Åkerström (Sweden)

Surgical aspects of neuroendocrine tumours  

W.D. Travis (USA)

Lung tumours with neuroendocrine differentiation  

K. Frank-Raue (Germany)

Multiple endocrine neoplasia type 2 (MEN 2)  

I.J. Virgolini (Austria)

Role of radiopharmaceuticals in the diagnosis and treatment of neuroendocrine tumours (NETs)  

Teaching Lecture: Treatment of limited disease - small cell lung cancer

D. De Ruysscher (The Netherlands)

Treatment of limited disease - small cell lung cancer  

Teaching Lecture: Antiemetics - state of the art

J. Herrstedt (Denmark)

Antiemetics: state of the art  

Teaching Lecture: How to perform translational research in melanoma

A. Spatz (Canada)

How to perform translational research in melanoma  

Teaching Lecture: An update of sentinel node biopsy on breast cancer

R.E. Mansel (United Kingdom)

An update of sentinel node biopsy on breast cancer  

Teaching Lecture: Epigenetic information in chromatin and cancer

Z. Herceg (France)

Epigenetic information in chromatin and cancer  

Teaching Lecture: Current treatment of high risk testis cancer

H. Schmoll (Germany)

Current treatment of high risk testis cancer  

Teaching Lecture: Value of quality indicators for cancer services

U. Wagner (Switzerland)

Value of quality indicators for cancer services  

Teaching Lecture: PSA screening-review of recent studies

F.H. Schröder (The Netherlands)

PSA screening - a review of recent studies  

Educational Symposium: Prostate cancer - therapeutic options after relapse

T. de Reijke (The Netherlands)

Treatment of local progression following radiotherapy  

T. Wiegel (Germany)

Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer  

K. Miller (Germany)

Hormonal treatment for progression  

R. De Wit (The Netherlands)

Chemotherapy in patients with castration resistant prostate cancer  

Teaching Lecture: Mission accomplished or work in progress - laparoscopic vs open colorectal surgery

W. Schwenk (Germany)

Mission accomplished or work in progress - laparoscopic vs open colorectal surgery  

Teaching Lecture: Bisphosphonates for care and cure

J.-J. Body (Belgium)

Bisphosphonates for care and cure  

Educational Symposium: Can there be generalised recommendations for multimodality treatment in stage III NSCLC?

J. Vansteenkiste (Belgium)

The multidisciplinarity of stage III NSCLC  

P. Van Schil (Belgium)

Surgical treatment of stage III NSCLC  

W. Eberhardt (Germany)

Chemotherapy in stage III NSCLC  

J. Vansteenkiste (Belgium)

Conclusion: generalised or personalized treatment?  

Teaching Lecture: Rare tumours of the chest

E. Felip Font (Spain)

Rare tumours of the chest  

Teaching Lecture: Allogeneic blood stem cell transplantation

M. Bornhauser (Germany)

Allogeneic blood stem cell transplantation  

Teaching Lecture: Re-irradiation in brain tumours - evidence, indications and limitations

S. Short (United Kingdom)

Re-irradiation in brain tumours - evidence, indications and limitations  

Educational Symposium: All you wanted to know about cancer stem cells but were afraid to ask

M. Alison (United Kingdom)

Stem cells and cancer in the aerodigestive tract  

B. Groner (Germany)

Mammary epithelial and breast cancer stem cells  

H.E. Johnsen (Denmark)

Cancer stem cells and the cellular hierarchy in haematological malignancies  

Teaching Lecture: Cancer and nutrition - key determinants of quality of life

P. Ravasco (Portugal)

Cancer and nutrition - key determinants of quality of life  

Teaching Lecture: New agents for metastatic prostate cancer

K. Fizazi (France)

New agents for metastatic prostate cancer  

Teaching Lecture: Particle therapy – physical, technical and clinical aspects

J. Debus (Germany)

Particle therapy – physical, technical and clinical aspects  

Educational Symposium: Clinical relevance of the triple negative breast cancer concept

G. Viale (Italy)

Pathological definition of triple negative breast cancer  

L.J. van 't Veer (USA)

Clinical relevance of the triple negative breast cancer concept: genetic basis and clinical utility of the concept  

C. Caldas (United Kingdom)

Triple negative breast cancers: clinical and prognostic implications  

C. Jackisch (Germany)

Therapeutic approach of early and advanced triple negative breast cancer  

Teaching Lecture: Neoadjuvant chemotherapy for breast cancers: current recommendations and future directions

F. Andre (France)

Neoadjuvant chemotherapy for breast cancers: current recommendations and future directions  

Educational Symposium: Systemic treatment of advanced colorectal cancer

C. Köhne (Germany)

Systemic treatment of advanced colorectal cancer - clinical predictive factors  

C.J.A. Punt (The Netherlands)

Chemotherapy - which drugs and when?  

J. Cassidy (United Kingdom)

How to integrate biologicals in the continuum of care  

E. Van Cutsem (Belgium)

Impact of molecular markers on treatment selection in advanced colorectal cancer  

J. Tabernero (Spain)

New approaches and targets in advanced colorectal cancer  

Teaching Lecture: Lung cancer screening

R.J. Van Klaveren (The Netherlands)

Lung cancer screening with low-dose CT: where do we stand today ?  

L.M. Montuenga (Spain)

Current challenges in lung cancer early detection biomarkers  

Teaching Lecture: Therapy of diffuse large B-cell lymphomas

M. Pfreundschuh (Germany)

Therapy of diffuse large B-cell lymphomas  

Teaching Lecture: HPV and prognosis for patients with oropharynx cancer

M.L. Gillison (USA)

HPV and prognosis for patients with oropharynx cancer  

Teaching Lecture: New approaches to clinical trial design for rare tumours including childhood cancer

M. Le Deley (France)

New approaches to clinical trial design for rare tumours including childhood cancer  

Teaching Lecture: Micro RNA's and their antagonists as novel therapeutics

N. Shomron (Israel)

MicroRNAs and their antagonists as novel therapeutics